Michael Barbella, Managing Editor09.03.22
New products, partnerships, and personnel dominated ODT page views this past week.
Rivals Zimmer Biomet and Stryker Corp. each announced new products/partnerships on the same day, while University of Cambridge researchers touted the development of new smart sensors.
Zimmer Biomet Holdings entered into an exclusive, multi-year co-marketing agreement with Surgical Planning Associates Inc. to commercialize HipInsight, the first U.S. Food and Drug Administration-cleared mixed reality navigation system for total hip replacement. HipInsight is customized for Zimmer Biomet's hip implant portfolio and allows surgeons to use Microsoft HoloLens 2 glasses to visualize a hologram of the patient's pelvic anatomy projected on the pelvis during surgery to support implant placement and alignment. HipInsight, the latest addition to the OptiVu Mixed Reality portfolio of applications, further expands the capabilities of the ZBEdge suite of integrated smart, digital and robotic technologies designed to deliver transformative data-powered insights with the goal of optimizing patient outcomes.
Stryker countered Zimmer Biomet's announcement by launching the Gamma4 system, the latest generation of its 30-year legacy intramedullary nailing system. Gamma4 treats stable and unstable fractures as well as stabilizes bones and corrects bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur (including osteoporotic and osteopenic bone). The system features a Precision pin, which reduces potential for skiving. A redefined nail design features length-dependent RoC, shortened proximal body, and chamfered distal tip with pre-inserted set screw. The nail also has an integrate instrument platform.
Rounding out the new product blitz was Cambridge University's promotion of its smart sensors—still under development—which assist in the soft tissue balancing and correct positioning of an orthopedic implant during hip replacement. The microfluidic force sensors are being developed within the University of Cambridge laboratory of Professor Sohini Kar-Narayan, in close collaboration with Vikas Khanduja, a consultant orthopedic surgeon at Addenbrooke’s Cambridge University Hospitals NHS Trust.
CoNextions drove website traffic with the announcement of its new president and CEO, as did a feature (July-August issue) on additive manufacturing at the point of care.
Rivals Zimmer Biomet and Stryker Corp. each announced new products/partnerships on the same day, while University of Cambridge researchers touted the development of new smart sensors.
Zimmer Biomet Holdings entered into an exclusive, multi-year co-marketing agreement with Surgical Planning Associates Inc. to commercialize HipInsight, the first U.S. Food and Drug Administration-cleared mixed reality navigation system for total hip replacement. HipInsight is customized for Zimmer Biomet's hip implant portfolio and allows surgeons to use Microsoft HoloLens 2 glasses to visualize a hologram of the patient's pelvic anatomy projected on the pelvis during surgery to support implant placement and alignment. HipInsight, the latest addition to the OptiVu Mixed Reality portfolio of applications, further expands the capabilities of the ZBEdge suite of integrated smart, digital and robotic technologies designed to deliver transformative data-powered insights with the goal of optimizing patient outcomes.
Stryker countered Zimmer Biomet's announcement by launching the Gamma4 system, the latest generation of its 30-year legacy intramedullary nailing system. Gamma4 treats stable and unstable fractures as well as stabilizes bones and corrects bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur (including osteoporotic and osteopenic bone). The system features a Precision pin, which reduces potential for skiving. A redefined nail design features length-dependent RoC, shortened proximal body, and chamfered distal tip with pre-inserted set screw. The nail also has an integrate instrument platform.
Rounding out the new product blitz was Cambridge University's promotion of its smart sensors—still under development—which assist in the soft tissue balancing and correct positioning of an orthopedic implant during hip replacement. The microfluidic force sensors are being developed within the University of Cambridge laboratory of Professor Sohini Kar-Narayan, in close collaboration with Vikas Khanduja, a consultant orthopedic surgeon at Addenbrooke’s Cambridge University Hospitals NHS Trust.
CoNextions drove website traffic with the announcement of its new president and CEO, as did a feature (July-August issue) on additive manufacturing at the point of care.
